
|Videos|October 31, 2015
How the FDA Views Compounding
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
Advertisement
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
This video was recorded at the 2015 NCPA Annual Convention.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
2
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
3
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
4
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
5



















































































































